Positron emission tomography radiotracers for imaging hypoxia (Q38166980)

30 August 2017

title

Positron emission tomography radiotracers for imaging hypoxia (English)

1 reference

positron emission tomography

30 August 2017

main subject

1 reference

Melinda Wuest

1

1 reference

30 August 2017

Frank Wuest

series ordinal

2

1 reference

30 August 2017

publication date

1 March 2013

1 reference

Journal of Labelled Compounds and Radiopharmaceuticals

30 August 2017

published in

1 reference

30 August 2017

volume

56

1 reference

30 August 2017

issue

3-4

1 reference

30 August 2017

page(s)

244-250

1 reference

Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis

30 August 2017

cites work

1 reference

Pathology: cancer cells compress intratumour vessels.

21 January 2018

1 reference

Microenvironmental and cellular consequences of altered blood flow in tumours

21 January 2018

1 reference

Imaging hypoxia and angiogenesis in tumors

21 January 2018

1 reference

Positron emission tomography as a tool for translational research in oncology

21 January 2018

1 reference

Treatment resistance of solid tumors: role of hypoxia and anemia

21 January 2018

1 reference

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

Review of positron emission tomography tracers for imaging of tumor hypoxia

21 January 2018

1 reference

Molecular imaging of hypoxia with radiolabelled agents

21 January 2018

1 reference

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

21 January 2018

1 reference

A marker for hypoxic cells in tumours with potential clinical applicability

21 January 2018

1 reference

The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms

21 January 2018

1 reference

Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue

21 January 2018

1 reference

Fully automated one-pot synthesis of [18F]fluoromisonidazole

21 January 2018

1 reference

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole

21 January 2018

1 reference

Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival

21 January 2018

1 reference

The concept of the penumbra: can it be translated to stroke management?

21 January 2018

1 reference

Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation

21 January 2018

1 reference

Simple, column purification technique for the fully automated radiosynthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA).

21 January 2018

1 reference

Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology

21 January 2018

1 reference

Tracer level electrophilic synthesis and pharmacokinetics of the hypoxia tracer [(18)F]EF5.

21 January 2018

1 reference

[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure

21 January 2018

1 reference

A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5)

21 January 2018

1 reference

Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma

21 January 2018

1 reference

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma

21 January 2018

1 reference

Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio

21 January 2018

1 reference

Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer

21 January 2018

1 reference

Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging

21 January 2018

1 reference

PET imaging of hypoxia using [18F]HX4: a phase I trial

21 January 2018

1 reference

Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging

21 January 2018

1 reference

Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.

21 January 2018

1 reference

Radiolabelling and evaluation of novel haloethylsulfoxides as PET imaging agents for tumor hypoxia

21 January 2018

1 reference

Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research

21 January 2018

1 reference

Synthesis and Characterization of Nitroimidazole Derivatives for 68Ga-Labeling and Testing in Tumor Xenografted Mice

21 January 2018

1 reference

Adduct of 2-[18F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: synthesis, in vitro- and in vivo-characterization

21 January 2018

1 reference

In vitro and in vivo evaluations of a hydrophilic 64Cu-bis(thiosemicarbazonato)-glucose conjugate for hypoxia imaging

21 January 2018

1 reference

Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.

21 January 2018

1 reference

Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals.

21 January 2018

1 reference

Molecular Imaging of Hypoxia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JLCR.2997

1 reference

30 August 2017

1 reference